This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alpert, M. A. Articles by Sullivan, W. D. Search for Related Content PubMed PubMed Citation Articles by Alpert, M. A. Articles by Sullivan, W. D.

Circulation, Vol 68, 1182-1193, Copyright © 1983 by American Heart Association

ARTICLES

Cardiovascular manifestations of mixed connective tissue disease in adults

MA Alpert, SH Goldberg, BH Singsen, JB Durham, GC Sharp, M Ahmad, NP Madigan, DP Hurst and WD Sullivan

To assess the nature and distribution of cardiovascular abnormalities associated with mixed connective tissue disease, we studied 38 patients with overlapping clinical manifestations of systemic lupus erythematosus, progressive systemic sclerosis and polymyositis, and circulating antibodies to nuclear ribonucleoprotein. The protocol included taking a medical history and a physical echocardiogram, and pulmonary function tests. Cardiac catheterization was performed on 17 patients. Postmortem examination was performed on four of the five patients who died during follow-up. Acute pericarditis and/or pericardial effusion was detected in 11 patients (29%) and mitral valve prolapse was identified in 10 patients (26%). Marked intimal hyperplasia of coronary arteries was observed in all four hearts that were autopsied and perivascular and myocardial leukocytic aggregates were present in two hearts. Pulmonary vascular resistance was elevated in 11 of the 17 patients who underwent cardiac catheterization. In summary, cardiovascular abnormalities associated with mixed connective tissue disease include acute pericarditis and/or effusion, mitral valve prolapse, intimal hyperplasia of coronary arteries, perivascular and myocardial leukocytic infiltrates, and pulmonary hypertension.

This article has been cited by other articles:

				S. D. Swain, S. Han, A. Harmsen, K. Shampeny, and A. G. Harmsen Pulmonary Hypertension Can Be a Sequela of Prior Pneumocystis Pneumonia Am. J. Pathol., September 1, 2007; 171(3): 790 - 799. [Abstract] [Full Text] [PDF]

				D. Weihrauch, H. Xu, Y. Shi, J. Wang, J. Brien, D. W. Jones, S. Kaul, R. A. Komorowski, M. E. Csuka, K. T. Oldham, et al. Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1432 - H1441. [Abstract] [Full Text] [PDF]

				M. S. Carneiro-Ramos, G. P. Diniz, J. Almeida, R. L. P. Vieira, S. V. B. Pinheiro, R. A. Santos, and M. L. M. Barreto-Chaves Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism J. Physiol., August 15, 2007; 583(1): 213 - 223. [Abstract] [Full Text] [PDF]

				I E Lundberg Cardiac involvement in autoimmune myositis and mixed connective tissue disease Lupus, September 1, 2005; 14(9): 708 - 712. [Abstract] [PDF]

				M C Bezerra, F Saraiva Jr, J F Carvalho, M T. Caleiro, C R Goncalves, and E F Borba Letter to the Editor Lupus, August 1, 2004; 13(8): 618 - 620. [PDF]

				J. J Jang, J. W Olin, and V. Fuster A teenager with mixed connective tissue disease presenting with an acute coronary syndrome Vascular Medicine, February 1, 2004; 9(1): 31 - 34. [Abstract] [PDF]

				G C Sharp MCTD: a concept which stood the test of time Lupus, June 1, 2002; 11(6): 333 - 339. [PDF]

				B.M Weiss and O.M Hess Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives Eur. Heart J., January 2, 2000; 21(2): 104 - 115. [PDF]

				O. Sanchez, M. Humbert, O. Sitbon, and G. Simonneau Treatment of pulmonary hypertension secondary to connective tissue diseases Thorax, March 1, 1999; 54(3): 273 - 277. [Full Text]

				R. Mier, B. Ansell, M. Hall, N. Hasson, J. Levinson, D. Lovell, M. Passo, R. Rennebohm, and P. Woo Long term follow-up of children with mixed connective tissue disease Lupus, June 1, 1996; 5(3): 221 - 226. [Abstract] [PDF]

				M. A. Alpert, M. D. Concannon, B. Mukerji, and V. Mukerji Pharmacotherapy of Chronic Pulmonary Arterial Hypertension: Value and Limitations: Part II: Secondary Pulmonary Hypertension Angiology, September 1, 1994; 45(9): 755 - 761. [Abstract] [PDF]

				T. A. Pressly, A. Winkler, M. A. Alpert, R. W. Jackson, V. Mukerji, J. M. Benge, and G. C. Sharp Value and Limitations of Calcium Channel Blockade In the Treatment of Pulmonary Hypertension Associated with CREST Case Reports Angiology, April 1, 1988; 39(4): 385 - 389. [Abstract] [PDF]